Literature DB >> 28124228

The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome.

Jovica Saponjski1, Ljudmila Stojanovich2, Jelena Petrovic3, Dusan Saponjski4.   

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease which is characterized by arterial and venous thromboses, fetal loss, and the presence of antiphospholipid antibodies in the serum. It is characterized by accelerated atherosclerosis. Increased tendency towards thrombosis leads to the occurrence of various vascular events. The objective of our study was to determine if there are subclinical changes on lower limb arteries in APS patients and what the best diagnostic choice for their establishment is. In this study, we analyzed 50 patients with primary antiphospholipid syndrome (PAPS) and 50 patients, who have secondary antiphospholipid syndrome (SAPS). The results were compared to 50 controls. The groups were comparable with respect to age, gender, and traditional risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. Study was conducted on 64-multi-slice computed tomography (64-MSCT), where we analyzed quantitative and morphological characteristics of blood vessel-detected lesions. Patients from the control group had statistically very significant elevated cholesterol and triglyceride levels in regard to the patients with SAPS and PAPS (p < 0.001 and p < 0.05). Analyzing percentage of diameter stenosis, we have established that lesions from group with 0-30% diameter stenosis (DS) in patients with PAPS (n = 47) and SAPS (n = 39) are more common than that in control group (n = 3, p < 0.001). The incidence of lesions higher than 70% DS in control group (n = 74) was statistically significant than that in patients with SAPS (n = 74, p < 0.05), while very statistically significant than that in patients with PAPS (n = 48, p < 0.001). Analyzing the qualitative characteristics of plaques, we have established significant higher frequency of soft tissue (n = 32) and mixed lesions (n = 36) in patients with PAPS than the calcified one (n = 7, p < 0.001). Our study showed that the subclinical manifestation of changes on lower extremity arteries is more common in patients with APS. Because of its safety and accuracy, the method of choice is 64-MSCT angiography in monitoring disease progression.

Entities:  

Keywords:  64-multi-slice computed tomography; Antiphospholipid syndrome; Vascular manifestations

Mesh:

Year:  2017        PMID: 28124228     DOI: 10.1007/s12026-016-8887-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  23 in total

Review 1.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

2.  Asherson's syndrome - catastrophic antiphospholipid syndrome.

Authors:  J Rovenský
Journal:  Autoimmun Rev       Date:  2006-07-21       Impact factor: 9.754

3.  Comparison of CT and MR angiography in evaluation of peripheral arterial disease before endovascular intervention.

Authors:  Alessandro Cina; Carmine Di Stasi; Vittorio Semeraro; Riccardo Marano; Giancarlo Savino; Roberto Iezzi; Lorenzo Bonomo
Journal:  Acta Radiol       Date:  2015-07-15       Impact factor: 1.990

4.  Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis--findings from a randomized controlled trial.

Authors:  Herbert Langenberger; Martin Schillinger; Christina Plank; Schila Sabeti; Petra Dick; Manfred Cejna; Johannes Lammer; Erich Minar; Christian Loewe
Journal:  Eur J Radiol       Date:  2011-06-23       Impact factor: 3.528

5.  Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus.

Authors:  Christopher Robert Crome; Sriram Rajagopalan; Ganesh Kuhan; Nicholas Fluck
Journal:  BMJ Case Rep       Date:  2012-11-20

6.  Acute Limb-Threatening Ischemia Associated With Antiphospholipid Syndrome: A Report of Two Cases.

Authors:  Kiwako Suzuki; Tetsuji Uemura; Mamoru Kikuchi; Yasuhiro Ishihara; Shigeru Ichioka
Journal:  J Foot Ankle Surg       Date:  2016-02-19       Impact factor: 1.286

7.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

Review 8.  Antiphospholipid syndrome.

Authors:  Guillermo Ruiz-Irastorza; Mark Crowther; Ware Branch; Munther A Khamashta
Journal:  Lancet       Date:  2010-09-06       Impact factor: 79.321

Review 9.  Imaging findings in systemic lupus erythematosus.

Authors:  Tasneem A Lalani; Jeffrey P Kanne; Gregory A Hatfield; Phebe Chen
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

10.  Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data.

Authors:  P R J Ames; A Margarita; K B Sokoll; M Weston; V Brancaccio
Journal:  Ann Rheum Dis       Date:  2004-05-21       Impact factor: 19.103

View more
  2 in total

1.  Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.

Authors:  Jovica Saponjski; Ljudmila Stojanovich; Jelena Saponjski; Milorad Mirilovic; Dusan Saponjski
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

2.  Editorial: Cutting edge in systemic lupus erythematosus.

Authors:  David P D'Cruz; Annegret Kuhn
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.